109
Participants
Start Date
November 30, 2006
Primary Completion Date
July 31, 2015
Study Completion Date
February 29, 2016
PLX4032
Oral capsules administered BID
Peter MacCallum Cancer Centre, East Melbourne
Memorial Sloan-Kettering Cancer Center, New York
University of Pennsylvania, Philadelphia
Vanderbilt Ingram Cancer Center, Nashville
MD Anderson Cancer Center, Houston
University of California Los Angeles, Los Angeles
Royal Melbourne Hospital, Parkville
Lead Sponsor
Roche Pharma AG
INDUSTRY
Plexxikon
INDUSTRY